Back to Results
First PageMeta Content
Amides / Benzofurans / Ramelteon / Sedatives / Pharmacology / Sleep disorders / Melatonin receptor agonist / Insomnia / Donepezil / Chemistry / Organic chemistry / Medicine


Page 1 of 19 FDA Final Labeling[removed]Supp[removed]
Add to Reading List

Document Date: 2010-11-17 08:37:16

Open Document

File Size: 126,88 KB

Share Result on Facebook

City

Impairment Reference / Action Reference / Elimination Reference / Reference / /

Company

Takeda Pharmaceuticals America Inc. / Takeda Pharmaceuticals / Inc. / /

Event

FDA Phase / Product Issues / /

Facility

Laboratory Test Interactions ROZEREM / Laboratory Tests Monitoring No / Laboratory Test Interactions USE IN SPECIFIC POPULATIONS / Poison Control Center / Laboratory Tests ADVERSE REACTIONS / Laboratory Tests Reference ID / A laboratory / /

IndustryTerm

treatment of insomnia / machinery / food / heavy machinery / chemical / /

MedicalCondition

medical illness / severe sleep apnea / central apnea / COPD / headache / obstructive sleep apnea / galactorrhea / hallucinations / nausea / anaphylaxis / angioedema involving / additive psychomotor impairment / severe COPD / exacerbated insomnia / fatigue / physical disorder / chronic insomnia / Concomitant Illness / insomnia / airway obstruction / dyspnea / Amnesia / Carcinogenesis / Chronic Obstructive Pulmonary Disease / chronic intermittent use / chronic / mania / Apnea / psychiatric disorder / vomiting / Sleep Apnea / angioedema / dizziness / Depression / /

MedicalTreatment

Hemodialysis / dialysis / /

Organization

Oral administration / DOSAGE AND ADMINISTRATION / FDA / /

/

Position

General / Major / /

Product

Luvox / ROZEREM / polyethylene glycol / albuterol / RAM / Rifampin / Fluconazole / diazepam / testosterone / Donepezil / Ketoconazole / dimethyl sulfoxide / activities / /

Technology

RAM / drug screening / Pharmacokinetics / dialysis / /

URL

www.fda.gov/medwatch / /

SocialTag